Eupraxia Pharmaceuticals Closes US$63.2 Million Public Offering

Mintz and Stikeman Elliott LLP have advised the underwriters. Troutman Pepper and Blake, Cassels & Graydon LLP have advised Eupraxia Pharmaceuticals. Eupraxia Pharmaceuticals Inc., a clinical-stage…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here